aibioACUT Accustem Sciences Inc.
Accustem Sciences (ACUT) news
Top story · Aug 14, 2026 · SEC filing 10-Q
Accustem Sciences files its quarterly report
Latest Accustem Sciences news
We have not published a story on Accustem Sciences yet. When there is news, it will appear here.
Accustem Sciences annual financials
| Line | FY2025 | FY2024 |
|---|---|---|
| Research and development | $281,014 | $138,324 |
| Net income (loss) | -$1.8 million | -$1.5 million |
| Cash from operations | -$850,389 | -$664,066 |
Questions about Accustem Sciences
What is the ticker symbol of Accustem Sciences?
Accustem Sciences Inc. trades under the ticker ACUT on OTC.
Where is Accustem Sciences listed?
Accustem Sciences Inc. is listed on OTC.
What is the SEC CIK of Accustem Sciences?
The SEC Central Index Key (CIK) for Accustem Sciences Inc. is 1850767. Its filings are on SEC EDGAR.
How many shares does Accustem Sciences have outstanding?
16,072,267 shares as of 2026-08-14, per the cover page of its 10-Q filed 2026-08-14.
Which country or territory is Accustem Sciences listed under?
Our directory records Accustem Sciences Inc. under United States.
What does Accustem Sciences do?
Our directory classifies Accustem Sciences Inc. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.
What is the ISIN of Accustem Sciences?
The ISIN recorded for Accustem Sciences Inc. is US00444A1016.
Does aibio.space cover Accustem Sciences?
aibio.space lists Accustem Sciences Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
Where is Accustem Sciences incorporated?
SEC records list its state or country of incorporation as DE.
Is Accustem Sciences profitable?
Accustem Sciences Inc. reported a net loss of $1.8 million for the fiscal year ended Dec 31, 2025, and used $850,389 of cash in operations, per its annual report to the SEC.
How much does Accustem Sciences spend on research and development?
$281,014 in the fiscal year ended Dec 31, 2025, per its annual report.
What is Accustem Sciences's market cap?
We do not publish live share prices. In its annual report, Accustem Sciences Inc. put the market value of shares held by non-affiliates (public float) at $9.7 million as of Jun 30, 2025.
Is Accustem Sciences a smaller reporting company?
SEC records list Accustem Sciences Inc.'s filer category as: Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company.
Where is Accustem Sciences headquartered?
SEC records list its business address as 5 PENN PLAZA, 19TH FLOOR, NEW YORK, NY, 10001.
When does Accustem Sciences's fiscal year end?
Accustem Sciences Inc.'s fiscal year ends on December 31, per SEC records.
Investor discussion: Accustem Sciences
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
- Distress
Reported substantial doubt about its ability to continue as a going concern. SEC Form 10-K. Source
- Distress
Told the SEC a periodic report would be filed late. SEC Form NT 10-K. Source
- Distress
Told the SEC a periodic report would be filed late. SEC Form NT 10-Q. Source
- Distress
Reported substantial doubt about its ability to continue as a going concern. SEC Form 10-K. Source
- Distress
Told the SEC a periodic report would be filed late. SEC Form NT 10-K. Source
- Legal
Reported a change of independent auditor. SEC Form 8-K (Items 4.01). Source
- Distress
Told the SEC a periodic report would be filed late. SEC Form NT 10-Q. Source
Stock chart
SEC filings and registration
- SEC name
- Accustem Sciences Inc.
- CIK
- 1850767
- Industry (SIC)
- Pharmaceutical Preparations (2834)
- US tickers
- ACUT (OTC)
- State or country of incorporation
- DE
- Fiscal year ends
- December 31
- Filer category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Business address
- 5 PENN PLAZA, 19TH FLOOR, NEW YORK, NY, 10001
- Phone
- 442070661000
- Shares outstanding
- 16,072,267 as of 2026-08-14 (10-Q filed 2026-08-14)
- Former names
- AccuStem Sciences Ltd
Recent filings
Listing details
- Company
- Accustem Sciences Inc.
- Ticker
- ACUT
- Listing
- OTC
- Country or territory
- United States
- Business scope
- Pharmaceuticals: Major
- ISIN
- US00444A1016
- Last quote in directory
- 2026-10-08
- Directory source
- Listing page
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction